VincentRK: For those of you interested in multiple myeloma, here is a brief state of the science for treatment. 1/ For newly diagnosed patients, triplets, VRd or DRd, are the standard of care. Current RCTs are examining if we can improve outcome using quadruplets. Eg. PERSEUS trial.

by | Jun 12, 2021 | Twitter | 0 comments

For those of you interested in multiple myeloma, here is a brief state of the science for treatment.

1/ For newly diagnosed patients, triplets, VRd or DRd, are the standard of care. Current RCTs are examining if we can improve outcome using quadruplets. Eg. PERSEUS trial. pic.twitter.com/hTULOO80Mx

— Vincent Rajkumar (@VincentRK) June 12, 2021

Submit a Comment